ARCHIVES

Funding opportunities listed.

This article is from The Cancer Letter archive.

Vol. 30 No. 07 | February 13, 2004

Download PDF Visit The Full Archive

Related Articles

NCI Approved CTEP Trials For the Month of August

August 31, 2012

Bayer’s HER-2/neu Blood Test Cleared By FDA For Marketing.

December 15, 2000

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

July 27, 2007

“Significant changes should be made to reduce redundancy, streamline operations, promote collaboration, and optimize productivity.”

July 14, 1995

NIH Reconsiders Closing A Meeting Of Advisory Group

January 13, 1995

Von Eschenbach Candidacy for FDA Hampered By Three Republican Holds.

December 1, 2006